Bongardia chrysogonum
Bongardia chrysogonum · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Bongardia chrysogonum is a unique botanical species that has garnered scientific interest due to its complex biochemical properties. Recent pharmacological investigations have focused on the plant's ability to influence specific biological pathways, particularly those involving tyrosinase inhibition. Researchers have primarily utilized ethanolic extracts of the tubers to explore these medicinal potential. Additionally, methanolic extracts have been studied to further characterize the plant's bioactive compounds. Understanding these extracts is essential for uncovering the full therapeutic scope of this remarkable organism.
- Synonyms
- Leontice Chrysogonum · Leontice Chrysogonia · 4 more
- Common names
- Not available
- Family
- Berberidaceae
- Distribution
- Asia-Tropical
- Plant Parts
- Not available
Classification
Common Names
Bongardia chrysogonum is a distinctive plant known by several evocative names across different languages. In English-speaking regions, it is affectionately referred to as the Golden Lady's Nightcap. This charming moniker reflects the unique appearance of its blossoms, which resemble a delicate cap. In German-speaking areas, the species is commonly called Goldene Nachtmütze. Regardless of the name used, this striking plant remains a fascinating subject for botanical enthusiasts worldwide.
Sources: Catalogue of Life (COL)
Synonyms
Bongardia chrysogonum is a species characterized by a complex taxonomic history involving several documented synonyms. Botanical records indicate that this plant has been previously identified under the names Bongardia olivieri and Bongardia rauwolfii. Furthermore, its classification has been linked to various iterations of the Leontice genus, specifically Leontice chrysogonia and Leontice chrysogum. The name Leontice oliveri also appears within its historical nomenclature, reflecting shifting scientific perspectives. Navigating these diverse synonyms is essential for researchers seeking to accurately identify this specific plant.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Bongardia chrysogonum is a unique botanical specimen belonging to the kingdom Plantae. Within this vast kingdom, the plant is categorized under the class Equisetopsida. It further falls into the order Ranunculales, showcasing its specific evolutionary lineage. As a member of the genus Bongardia, it holds a distinct place within its group. Finally, this plant is classified under the family Berberidaceae, completing its complex biological hierarchy.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ranunculales |
| Family | Berberidaceae |
| Genus | Bongardia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Bongardia chrysogonum is a resilient species with a broad geographical footprint spanning multiple continents. Its distribution stretches across Northern Africa, specifically within the regions of Libya. In the temperate zones of Asia, the plant is commonly found throughout the Caucasus and Transcaucasus areas. Furthermore, it thrives across parts of Central Asia, including Kazakhstan and Kirgizstan. This wide range highlights the plant's ability to adapt to diverse environmental conditions across its habitat.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Bongardia chrysogonum is characterized by its distinct growth form as a herbaceous plant. This species typically reaches a modest stature, maintaining a height that ranges between 0.3 m and 0.5 m. Such compact dimensions make it a notable feature within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Bongardia chrysogonum plays a significant role in the inhibition of various biological enzymes through its medicinal extracts. When synthesized into copper-nanoflowers, this plant demonstrates the ability to treat tyrosinase, α-amylase, and α-glucosidase. Additionally, the extracts are effective in treating acetyl and butyryl cholinesterase. These inhibitory activities are significantly enhanced when the plant extract is utilized in the formation of organic-inorganic hybrid nanoflowers. Such multifaceted enzymatic treatment highlights the potential therapeutic value of Bongardia chrysogonum in pharmaceutical applications.
Preparations
Bongardia chrysogonum is prepared as an ethanolic extract of the tubers to isolate specific triterpenoid saponins. Research has also shown that Bongardia chrysogonum is prepared as methanolic extracts for use in the synthesis of copper-nanoflowers. These organic-inorganic hybrid nanoflowers utilize the plant's extracts to enhance various enzyme inhibitory activities. Specifically, the methanolic extracts contribute to the development of plant extract-based-inorganic hybrid nanoflowers. Both preparation methods serve distinct scientific purposes ranging from chemical isolation to the creation of advanced pharmaceutical materials.